Skip to main content
OpenTrials

Clinical trial condition

Lipodystrophy, Congenital Generalized

Explore clinical trials studying Lipodystrophy, Congenital Generalized. Study availability and eligibility vary by location and protocol.

14 public trials 5 recruiting studies
Refine in advanced search Browse all conditions

Lipodystrophy, Congenital Generalized trial results

Recruiting

MEASuRE: Metreleptin Effectiveness And Safety Registry

NCT02325674

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Generalised Lipodystrophy, Genetic Diseases, Inborn, +12 more
Locations
  • University Alabama at Birmingham Birmingham, Alabama, United States
  • City of Hope Duarte, California, United States
  • Atlanta Diabetes Associates Atlanta, Georgia, United States
  • Ann & Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States
View all 28 locations
View Trial Details
Completed

Study of REGN4461, a Leptin Receptor Agonist Antibody, in Patients With Generalized Lipodystrophy

NCT04159415

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Generalized Lipodystrophy, Genetic Diseases, Inborn, +10 more
Locations
  • Regeneron Research Site Bethesda, Maryland, United States
  • Regeneron Research Site Ann Arbor, Michigan, United States
  • Regeneron Research Site Dallas, Texas, United States
  • Regeneron Research Site Piura, Peru
View Trial Details
Completed

Immunogenicity of Metreleptin in Patients With Generalized Lipodystrophy

NCT04026178

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Generalized Lipodystrophy, Genetic Diseases, Inborn, +10 more
Locations
  • Univ. Alabama-Birmingham Birmingham, Alabama, United States
  • Ochsner Clinic New Orleans, Louisiana, United States
  • University of Michigan Ann Arbor, Michigan, United States
  • Endocrinology Research Associates Columbus, Ohio, United States
View Trial Details

Related conditions